Biotech Investors & VC Firms in Latin America

163 firms in this list, with a median first check of $425K. 55 of them lead rounds. Generated from verified public data and updated continuously.

Fund	FoxScore	HQ	Invests	Stage	Check	CRM
SO Socii Capital JBSMYCGS5 people · Follows rounds	88🔒	San Francisco	US	Series A–Series B	—	+ Add to CRM
PE Petri JGJMTKRW6 people	88🔒	Boston	US	Pre-Seed	$100K – $6M	+ Add to CRM
HI Hillhouse Capital Leads rounds	88🔒	Changyang	CN	Seed–Series C	$2.9M – $220M	+ Add to CRM
SA Saba Investments AARMAIEE8 people	88🔒	El Paso	US	Seed–Series A	$200K	+ Add to CRM
MS MSA Capital JZYXYZHK4 people · Leads rounds	88🔒	Grand Cayman	CN	Pre-Seed–Late Stage	$1.4M – $130M	+ Add to CRM
SV SVG Ventures HHJHDOGY9 people · Leads rounds	88🔒	Silicon Valley	US	Pre-Seed–Series A	—	+ Add to CRM
D3 D3 Jubilee 윤이임김11 people	88🔒	Seoul	KR	Seed–Late Stage	—	+ Add to CRM
FR FrissOn Capital PLATECEM11 people	88🔒	US-based	US	Pre-Seed	—	+ Add to CRM
SP Split Rock Partners JSMGSZDS4 people · Leads rounds	88🔒	Eden Prairie	US	Seed–Late Stage	$2M – $40M	+ Add to CRM
FU Future Positive Capital SHESPR3 people · Follows rounds	88🔒	—	FR	Pre-Seed–Series A	—	+ Add to CRM
DO DoubleRock NDSR2 people	88🔒	San Francisco	US	Seed–Series A	$2M – $15M	+ Add to CRM
LA Label Investments APLS2 people	88🔒	Pamplona	ES	Pre-Seed–Late Stage	$1.1M – $33M	+ Add to CRM
OU Outlier Ventures NRJB2 people	88🔒	Berkhamsted	GB	Pre-Seed–Series A	$50K – $100K	+ Add to CRM
ID IDB Lab GMCMCBLV7 people	88🔒	Washington, D.C.	US	Pre-Seed–Growth	—	+ Add to CRM
HB HBS Alumni Angels TLYBYH3 people · Leads rounds	88🔒	Palo Alto	US	Pre-Seed–Series A	$750K – $2M	+ Add to CRM
H. H.I.G. BioHealth Partners SMTTBSDB6 people	88🔒	—		Growth–Late Stage	—	+ Add to CRM
GL Global Startups Accelerator (formerly LatAm Startups) MLAACRMS8 people	88🔒	Toronto	CA	Pre-Seed–Seed	—	+ Add to CRM
IM Improve Ventures BTJCODYA5 people · Leads rounds	88🔒	Barcelona	ES	Pre-Seed–Series A	$100K – $1M	+ Add to CRM
MI Mirae Asset Venture Investment DBE(2 people	88🔒	—		Seed–Late Stage	$594K – $54M	+ Add to CRM
AB Aberdare Ventures SV1 person · Follows rounds	88🔒	San Francisco	US	Seed–Series A	$500K – $15M	+ Add to CRM
VI VIB CDJVDRLL5 people · Follows rounds	88🔒	Ghent	BE	Seed–Late Stage	—	+ Add to CRM
BR Brace Pharma DERSTB3 people	88🔒	Atlanta	US	Late Stage	—	+ Add to CRM
SY Syngenta Group Ventures DPJLMLSS7 people	88🔒	Durham	US	Seed–Growth	$500K – $5M	+ Add to CRM
RI Ride Home CM1 person · Follows rounds	88🔒	Lynnwood	US	Pre-Seed–Seed	$100K – $5M	+ Add to CRM

Socii Capital

San FranciscoSeries A–Series B

JBSMYCGS5 people

Petri

BostonPre-Seed$100K – $6M

JGJMTKRW6 people

Hillhouse Capital

ChangyangSeed–Series C$2.9M – $220M

Saba Investments

El PasoSeed–Series A$200K

AARMAIEE8 people

MSA Capital

Grand CaymanPre-Seed–Late Stage$1.4M – $130M

JZYXYZHK4 people

SVG Ventures

Silicon ValleyPre-Seed–Series A

HHJHDOGY9 people

D3 Jubilee

SeoulSeed–Late Stage

윤이임김11 people

FrissOn Capital

US-basedPre-Seed

PLATECEM11 people

Split Rock Partners

Eden PrairieSeed–Late Stage$2M – $40M

JSMGSZDS4 people

Future Positive Capital

Pre-Seed–Series A

SHESPR3 people

DoubleRock

San FranciscoSeed–Series A$2M – $15M

NDSR2 people

Label Investments

PamplonaPre-Seed–Late Stage$1.1M – $33M

APLS2 people

Outlier Ventures

BerkhamstedPre-Seed–Series A$50K – $100K

NRJB2 people

IDB Lab

Washington, D.C.Pre-Seed–Growth

GMCMCBLV7 people

HBS Alumni Angels

Palo AltoPre-Seed–Series A$750K – $2M

TLYBYH3 people

H.I.G. BioHealth Partners

Growth–Late Stage

SMTTBSDB6 people

Global Startups Accelerator (formerly LatAm Startups)

TorontoPre-Seed–Seed

MLAACRMS8 people

Improve Ventures

BarcelonaPre-Seed–Series A$100K – $1M

BTJCODYA5 people

Mirae Asset Venture Investment

Seed–Late Stage$594K – $54M

DBE(2 people

Aberdare Ventures

San FranciscoSeed–Series A$500K – $15M

SV1 person

VIB

GhentSeed–Late Stage

CDJVDRLL5 people

Brace Pharma

AtlantaLate Stage

DERSTB3 people

Syngenta Group Ventures

DurhamSeed–Growth$500K – $5M

DPJLMLSS7 people

Ride Home

LynnwoodPre-Seed–Seed$100K – $5M

CM1 person

Data sourced from public filings and firms' own websites — see our methodology.